Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Apellis Pharmaceuticals Inc
(NQ:
APLS
)
28.00
+0.08 (+0.29%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Apellis Pharmaceuticals Inc
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
16
17
Next >
Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session
July 31, 2023
Gainers Yellow Corporation (NASDAQ: YELL) shares jumped 106% to $1.46. The trucking company ceased operations on Sunday, according to a Wall Street Journal report.
Via
Benzinga
Apellis Crashes As Safety Issues Outweigh Massive Eye-Drug Sales Beat
July 31, 2023
Apellis crashed after Syfovre safety issues continued to plague the stock.
Via
Investor's Business Daily
Stocks That Hit 52-Week Lows On Monday
July 31, 2023
On Monday, 27 stocks hit new 52-week lows.
Via
Benzinga
Where Apellis Pharmaceuticals Stands With Analysts
July 18, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
July 31, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
July 31, 2023
Via
Benzinga
Rising Stars, Falling Trends: July's Industry ETF Winners And Losers
July 31, 2023
Via
Benzinga
Apellis Pharmaceuticals Stock Slips Despite Q2 Sales Beat Thanks To Syfovre, Empaveli
July 31, 2023
Apellis Pharmaceuticals Inc (NASDAQ: APLS) reported a second quarter (Q2) EPS loss of $1.02, beating the
Via
Benzinga
Why China Natural Resources Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
July 31, 2023
Gainers
Via
Benzinga
Apellis Pharmaceuticals Reports Second Quarter 2023 Financial Results
July 31, 2023
From
Apellis Pharmaceuticals, Inc.
Via
GlobeNewswire
SYFOVRE® (pegcetacoplan injection) Continued to Demonstrate Increasing Treatment Effects Over 30 Months in Patients with Geographic Atrophy (GA)
July 30, 2023
From
Apellis Pharmaceuticals, Inc.
Via
GlobeNewswire
Earnings Scheduled For July 31, 2023
July 31, 2023
Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million.
Via
Benzinga
Apellis Provides Update on Review of Rare Safety Events with SYFOVRE® (pegcetacoplan injection) for Geographic Atrophy
July 29, 2023
From
Apellis Pharmaceuticals, Inc.
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
July 28, 2023
Via
Benzinga
Alphabet, Boeing, Union Pacific And Other Big Stocks Moving Higher On Wednesday
July 26, 2023
U.S. stocks traded mixed, with the Dow Jones gaining around 50 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
July 28, 2023
Friday's session saw 59 companies set new 52-week lows.
Via
Benzinga
Tarsus Pharma Shares Under Pressure: Analyst Says Concerns Over Adverse Event Profile Overblown
July 25, 2023
The FDA approved Tarsus Pharmaceuticals Inc's (NASDAQ: TARS) Xdemvy (lotilaner ophthalmic solution) 0.25% for
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 25, 2023
On Tuesday, 56 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
July 26, 2023
Wednesday saw 59 companies set new 52-week lows.
Via
Benzinga
Apellis Pharmaceuticals to Host Conference Call on July 31, 2023, to Discuss Second Quarter 2023 Financial Results
July 24, 2023
From
Apellis Pharmaceuticals, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
July 24, 2023
On Monday morning, 70 companies achieved new lows for the year.
Via
Benzinga
Dow Jones Leads Market Advance As Tesla, Netflix, Taiwan Semiconductor Hit Growth: Weekly Review
July 21, 2023
But all the major indexes are at or near 15-month highs.
Via
Investor's Business Daily
APLS Investigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) Investors
July 21, 2023
From
Kessler Topaz Meltzer & Check, LLP
Via
Business Wire
Stocks That Hit 52-Week Lows On Thursday
July 20, 2023
During Thursday's session, 40 stocks hit new 52-week lows.
Via
Benzinga
Apellis's Stock Under Pressure On Syfovre Safety Concerns: Analyst Slashes Price Target
July 20, 2023
Since Friday, Apellis Pharmaceuticals Inc (NASDAQ: APLS) shares have plummeted around 50% after the stock came under pressure following the disclosure of
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 20, 2023
Via
Benzinga
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Apellis Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – APLS
July 18, 2023
From
The Rosen Law Firm, P.A.
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
July 18, 2023
During Tuesday's trading, 46 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
July 18, 2023
Via
Benzinga
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 18, 2023
Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring.
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.